ME Therapeutics Holdings Inc.
ME Therapeutics Holdings Inc.
CSE Index:
CSE25Currency:
CAD ME Therapeutics is an early stage Vancouver based biotechnology company involved in the discovery and development of novel immuno oncology therapeutics targeting immune suppression in cancer. Our main focus is on overcoming the suppressive effects of an important class of immune cells called myeloid cells in order to enhance anti-tumour immunity.
ME Therapeutics Holdings Inc. (METX)
10.00
0.00 (0.00%)
ME Therapeutics Holdings Inc. (METX)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Bid Size
100
Bid Price
8.00
Ask Price
9.97
Ask Size
400
Volume
0
Last Price
10.00
Tick
Net Change
Prev Close
10.00
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
11.00
52 Week Low
0.75
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
100
Bid Price
8.00
Ask Price
9.97
Ask Size
400
Volume
0
Last Price
10.00
Tick
Net Change
Prev Close
10.00
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
11.00
52 Week Low
0.75
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Bid Size
0
Bid Price
0.00
Ask Price
0.00
Ask Size
0
Volume
0
Last Price
Tick
Net Change
Prev Close
Open
0.00
Day High
0.00
Day Low
0.00
52 Week High
52 Week Low
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| TD Securities Inc. | 100 | 8.00 | 9.97 | 400 | Questrade Inc. |
| CIBC World Markets Inc. | 100 | 5.00 | 10.47 | 500 | Questrade Inc. |
| Anonymous | 200 | 4.00 | 10.50 | 500 | Anonymous |
| Anonymous | 100 | 2.50 | 10.60 | 500 | Anonymous |
| Anonymous | 3,000 | 0.01 | 10.70 | 500 | Anonymous |
| TD Securities Inc. | 300,000 | 0.005 | 10.80 | 500 | Anonymous |
| 0 | 0.00 | 10.90 | 500 | Anonymous | |
| 0 | 0.00 | 20.00 | 100 | Anonymous | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Broker | Bid Size | Bid Price | Ask Price | Ask Size | Ask Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 1 | 100 | 8.00 | 9.97 | 400 | 1 |
| 1 | 100 | 5.00 | 10.47 | 500 | 1 |
| 1 | 200 | 4.00 | 10.50 | 500 | 1 |
| 1 | 100 | 2.50 | 10.60 | 500 | 1 |
| 1 | 3,000 | 0.01 | 10.70 | 500 | 1 |
| Bid Count | Bid Size | Bid Price | Ask Price | Ask Size | Ask Count |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Time | Price | Change | Volume | Buyer | Seller | Venue |
|---|---|---|---|---|---|---|
| Apr 1, 13:30 | 10.00 | 0.00 | 100 | TD Securities Inc. | National Bank Financial Inc. | CSE |
| Mar 31, 19:57 | 7.50 | -2.50 | 100 | RBC Capital Markets | RBC Capital Markets | CSE |
| Mar 20, 16:39 | 10.50 | 0.50 | 100 | RBC Capital Markets | Anonymous | CSE |
| Mar 20, 15:52 | 9.00 | -1.00 | 1,000 | Questrade Inc. | Scotia Capital Inc. | CSE |
| Mar 19, 16:49 | 11.00 | 1.00 | 100 | National Bank Financial Inc. | RBC Capital Markets | CSE |
Company Info
Address
177 Robson St.
Vancouver, BC V6B 0N3
CanadaPhone
(236) 516-7714Email
Info@metherapeutics.comWebsite
https://www.metherapeutics.comListing date
Thursday, October 12, 2023Transfer Agent
Odyssey Trust CompanySEDAR Information
Filing Type
Any
News Releases
Management's Discussion & Analysis
Financial Statements
Material Change Report
Timeframe
1 week1 month3 month6 month1 yearAll Time
ME Therapeutics Holdings Inc.
Date:
Nov 26, 2024
ME Therapeutics Holdings Inc.
Date:
Nov 26, 2024
ME Therapeutics Holdings Inc.
Date:
Nov 26, 2024
ME Therapeutics Holdings Inc.
Date:
Jun 26, 2024
ME Therapeutics Holdings Inc.
Date:
Jun 26, 2024
ME Therapeutics Holdings Inc.
Date:
Mar 22, 2024
ME Therapeutics Holdings Inc.
Date:
Mar 22, 2024
ME Therapeutics Holdings Inc.
Date:
Mar 6, 2024
ME Therapeutics Holdings Inc.
Date:
Jan 26, 2024
ME Therapeutics Holdings Inc.
Date:
Jan 24, 2024
ME Therapeutics Holdings Inc.
Date:
Jan 24, 2024
ME Therapeutics Holdings Inc.
Date:
Dec 19, 2023
ME Therapeutics Holdings Inc.
Date:
Dec 19, 2023
ME Therapeutics Holdings Inc.
Date:
Dec 19, 2023
ME Therapeutics Holdings Inc.
Date:
Oct 12, 2023
ME Therapeutics Holdings Inc.
Date:
Aug 18, 2023
ME Therapeutics Holdings Inc.
Date:
Jul 6, 2023
ME Therapeutics Holdings Inc.
Date:
Apr 6, 2023
ME Therapeutics Holdings Inc.
Date:
Mar 8, 2023
Company Info
Address
177 Robson St.
Vancouver, BC V6B 0N3
CanadaPhone
(236) 516-7714Email
Info@metherapeutics.comWebsite
https://www.metherapeutics.comListing date
Thursday, October 12, 2023Transfer Agent
Odyssey Trust CompanyCapitalization
Issued & Outstanding:
25189438Reserved for Issuance:
12058890Company Officers
Salim Zulifkar Dhanji, Chief Executive Officer
Quinn Martin, Chief Financial Officer
Jamil Kassam, Corporate Secretary
Bulletins
10/10/2023
2023-1016 - New Listing - ME Therapeutics Holdings Inc. (METX)
le 10 octobre/October 2023
The common shares of ME Therapeutics Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
